Health - Wednesday, April 29, 2026

At Wednesday's argument, the justices did not appear to question whether skinny labeling is valid.

A headset recently approved by the Food and Drug Administration uses a weak electric current to shock the brain. Some researchers hope it could challenge the current pill-centric paradigm.

Prosecutors accused Dr. David Morens, a former adviser to Dr. Anthony S. Fauci, of hiding records related to the onset of the pandemic.

In this edition of AI Prognosis, Brittany Trang argues that the tide may be turning when it comes to how the health care industry talks about AI.

FDA sampled 312 major infant formula brands and found low or undetectable levels of pesticide residue, PFAS, heavy metals and phthalates.

A change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The Readout

The FDA announced efforts to make clinical trials more efficient, starting by reviewing data in real time from trials conducted by AstraZeneca and Amgen

A decades-old drug once used to treat sleeping sickness is now showing surprising promise against an ultra-rare and life-threatening genetic disorder called Bachmann-Bupp syndrome (BABS). Early patient treatments suggest the drug, DFMO, may ease severe symptoms by targeting the underlying genetic malfunction. Researchers have already treated a handful of patients with encouraging results, but progress has been slowed by regulatory and logistical hurdles.

An autism advisory committee finally meets again, antipsychotics and dementia, and more health news from Morning Rounds

A troubling new study from MIT reveals that a common environmental contaminant, NDMA—found in polluted water, certain medications, and even processed foods—may pose a far greater cancer risk to children than adults. In experiments with mice, young animals exposed to the chemical developed significantly more DNA damage and cancer, despite experiencing the same initial exposure as adults. The key difference lies in how rapidly children’s cells divide, which turns early DNA damage into dangerous mutations much more easily.